An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...

French dairy giant Bel Group and precision fermentation firm Standing Ovation have produced casein with dairy industry waste ...

Preclinical studies have shown CPV-104 to be functionally equivalent to endogenous human Factor H, with the ability to normalize serum C3 levels and promote clearance of pathogenic complement deposits ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

Uniproma proudly introduces RJMPDRN REC, shortlisted for the 2025 Best Ingredient Award at in-cosmetics Latin America. As the ...

Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...

Analyses of clinical and biologic determinants of melanoma bone metastasis (Mel-Bone). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid arthritis (RA).

Cathy Moore does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...